Aberrant signal transduction of TGF-β signaling may lead to a variety of tumors, including esophageal cancer, hepatocellular carcinoma, pancreatic cancer, gastric cancer, CRC, etc. [20]. Here, TGFB1 is linked to colorectal carcinoma.